Exercise as Maintenance Therapy in Advanced Lung Cancer
The purpose of this study is to examine how a multimodality (having or using a variety of methods to do something) exercise intervention may improve survival, function, and quality of life in participants with advanced lung cancer.
• Age ≥ 18 years
• Known diagnosis of locally advanced (stage III) or metastatic NSCLC
• Patient is currently receiving maintenance immunotherapy for at least 1 month and planned for at least 3 additional months of therapy
‣ Patients receiving maintenance therapy refers to patients with stable disease or partial response to therapy, including patients who have had a history of disease progression but are currently stable or responding to a different therapy
⁃ Patients previously receiving chemotherapy are eligible as long as at least one month has elapsed since completing chemotherapy. Those currently receiving chemotherapy are not eligible.
• Patient is willing and able to participate in a supervised home-based exercise program as determined by the MOVE program
• a.Participants must have internet access and equipment to participate in virtual exercise
• ECOG performance status of 0-2